Despite significant progress, cancer continues to pose a major health challenge. This is especially true for certain groups in the United States who continue to experience a disproportionate burden of cancer.
ACCC, in partnership with the Center for Business Models in Healthcare, is making 4R Care Sequences® available at no cost to ACCC Members.
4R Care Sequences® are guideline-based care plans for providers and patients, at diagnosis and at transitions between treatments.
From the 50th Annual Meeting & Cancer Center Business Summit, access the March 1, 2024 presentation, An Actionable Framework to Support Equitable and Comprehensive Care. Given by Al Benson III, MD, professor of medicine at Northwestern University Feinberg School of Medicine; Josephine Feliciano, MD, medical director, thoracic oncology program, and codirector, outpatient oncology clinic at Johns Hopkins Bayview Medical Center; and Julia Trosman, PhD, MBA, director of the Center for Business Models in Healthcare and adjunct assistant professor at Northwestern University Feinberg School of Medicine, this discussion covers how cancer programs have benefited from using 4R Care Sequences and how your program can access these resources for providers and patients at no cost.
4R Oncology® is the intellectual property of CBM-HC (Executive Frameworks, Ltd.), but is not a commercial product or service.
This final report from ACCC, Northwestern University, and the Center for Business Models in Healthcare shows how one multisite oncology practice built care coordination directly into its electronic health record. The program captured more than 100,000 minutes of non-face-to-face care coordination and used a structured EHR form to automatically generate personalized 4R Oncology® Care Sequence® plans for patients. The report includes a step-by-step framework and the technical architecture other cancer programs need to adopt the model.
In this episode, CANCER BUZZ speaks with Raymond Liu, MD, director of research of Hematology-Oncology in Kaiser Permanente Northern California, director of cancer survivorship in Kaiser Permanente San Francisco, and assistant clinical professor at UCSF, who shares how successful implementation of the 4R Oncology® model empowers patients and clinicians and coheres care teams.
4R Care Sequence® templates were developed based on studies sponsored by Genentech, Inc.
This program was made possible with support from AstraZeneca.
